141 related articles for article (PubMed ID: 21360526)
1. IL-9 is a Th17-derived cytokine that limits pathogenic activity in organ-specific autoimmune disease.
Stephens GL; Swerdlow B; Benjamin E; Coyle AJ; Humbles A; Kolbeck R; Fung M
Eur J Immunol; 2011 Apr; 41(4):952-62. PubMed ID: 21360526
[TBL] [Abstract][Full Text] [Related]
2. Invariant NKT cells regulate experimental autoimmune uveitis through inhibition of Th17 differentiation.
Oh K; Byoun OJ; Ham DI; Kim YS; Lee DS
Eur J Immunol; 2011 Feb; 41(2):392-402. PubMed ID: 21268009
[TBL] [Abstract][Full Text] [Related]
3. Both IFN-γ and IL-17 are required for the development of severe autoimmune gastritis.
Tu E; Ang DK; Bellingham SA; Hogan TV; Teng MW; Smyth MJ; Hill AF; van Driel IR
Eur J Immunol; 2012 Oct; 42(10):2574-83. PubMed ID: 22777705
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune inflammation from the Th17 perspective.
Furuzawa-Carballeda J; Vargas-Rojas MI; Cabral AR
Autoimmun Rev; 2007 Jan; 6(3):169-75. PubMed ID: 17289553
[TBL] [Abstract][Full Text] [Related]
5. IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo.
Sonderegger I; Kisielow J; Meier R; King C; Kopf M
Eur J Immunol; 2008 Jul; 38(7):1833-8. PubMed ID: 18546146
[TBL] [Abstract][Full Text] [Related]
6. Differential cytokine requirements for regulation of autoimmune gastritis and colitis by CD4(+)CD25(+) T cells.
Suri-Payer E; Cantor H
J Autoimmun; 2001 Mar; 16(2):115-23. PubMed ID: 11247637
[TBL] [Abstract][Full Text] [Related]
7. 1α,25-Dihydroxyvitamin D3 and all-trans retinoic acid synergistically inhibit the differentiation and expansion of Th17 cells.
Ikeda U; Wakita D; Ohkuri T; Chamoto K; Kitamura H; Iwakura Y; Nishimura T
Immunol Lett; 2010 Nov; 134(1):7-16. PubMed ID: 20655952
[TBL] [Abstract][Full Text] [Related]
8. Pre-differentiated Th1 and Th17 effector T cells in autoimmune gastritis: Ag-specific regulatory T cells are more potent suppressors than polyclonal regulatory T cells.
Huter EN; Stummvoll GH; DiPaolo RJ; Glass DD; Shevach EM
Int Immunopharmacol; 2009 May; 9(5):540-5. PubMed ID: 19539565
[TBL] [Abstract][Full Text] [Related]
9. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies.
Maddur MS; Miossec P; Kaveri SV; Bayry J
Am J Pathol; 2012 Jul; 181(1):8-18. PubMed ID: 22640807
[TBL] [Abstract][Full Text] [Related]
10. Distinct role of T helper Type 17 immune response for Graves' hyperthyroidism in mice with different genetic backgrounds.
Horie I; Abiru N; Saitoh O; Ichikawa T; Iwakura Y; Eguchi K; Nagayama Y
Autoimmunity; 2011 Mar; 44(2):159-65. PubMed ID: 20670120
[TBL] [Abstract][Full Text] [Related]
11. T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis.
Hirota K; Hashimoto M; Yoshitomi H; Tanaka S; Nomura T; Yamaguchi T; Iwakura Y; Sakaguchi N; Sakaguchi S
J Exp Med; 2007 Jan; 204(1):41-7. PubMed ID: 17227914
[TBL] [Abstract][Full Text] [Related]
12. IFN-γ and IL-12 synergize to convert in vivo generated Th17 into Th1/Th17 cells.
Lexberg MH; Taubner A; Albrecht I; Lepenies I; Richter A; Kamradt T; Radbruch A; Chang HD
Eur J Immunol; 2010 Nov; 40(11):3017-27. PubMed ID: 21061434
[TBL] [Abstract][Full Text] [Related]
13. IL-6: regulator of Treg/Th17 balance.
Kimura A; Kishimoto T
Eur J Immunol; 2010 Jul; 40(7):1830-5. PubMed ID: 20583029
[TBL] [Abstract][Full Text] [Related]
14. Opposing effect of mesenchymal stem cells on Th1 and Th17 cell polarization according to the state of CD4+ T cell activation.
Carrión F; Nova E; Luz P; Apablaza F; Figueroa F
Immunol Lett; 2011 Mar; 135(1-2):10-6. PubMed ID: 20888363
[TBL] [Abstract][Full Text] [Related]
15. A naturally occurring, soluble antagonist of human IL-23 inhibits the development and in vitro function of human Th17 cells.
Yu RY; Gallagher G
J Immunol; 2010 Dec; 185(12):7302-8. PubMed ID: 21076058
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-23 promotes Th17 differentiation by inhibiting T-bet and FoxP3 and is required for elevation of interleukin-22, but not interleukin-21, in autoimmune experimental arthritis.
Mus AM; Cornelissen F; Asmawidjaja PS; van Hamburg JP; Boon L; Hendriks RW; Lubberts E
Arthritis Rheum; 2010 Apr; 62(4):1043-50. PubMed ID: 20131264
[TBL] [Abstract][Full Text] [Related]
17. RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F.
Leppkes M; Becker C; Ivanov II; Hirth S; Wirtz S; Neufert C; Pouly S; Murphy AJ; Valenzuela DM; Yancopoulos GD; Becher B; Littman DR; Neurath MF
Gastroenterology; 2009 Jan; 136(1):257-67. PubMed ID: 18992745
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
[TBL] [Abstract][Full Text] [Related]
19. A positive feedback loop of IL-21 signaling provoked by homeostatic CD4+CD25- T cell expansion is essential for the development of arthritis in autoimmune K/BxN mice.
Jang E; Cho SH; Park H; Paik DJ; Kim JM; Youn J
J Immunol; 2009 Apr; 182(8):4649-56. PubMed ID: 19342640
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of post-thymectomy autoimmunity. Role of syngeneic MLR-reactive T cells.
Bonomo A; Kehn PJ; Payer E; Rizzo L; Cheever AW; Shevach EM
J Immunol; 1995 Jun; 154(12):6602-11. PubMed ID: 7759894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
